REVANCE THERAPEUTICS INC (RVNC)

US7613301099 - Common Stock

3.84  +0.04 (+1.05%)

After market: 3.976 +0.14 (+3.54%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
77.8M
408.50%		132.6M
70.44%		234.04M
76.50%		281.68M
20.36%
EBITDA
YoY % growth
-254.85M
3.08%		-238.47M
6.43%		-209.35M
12.21%		-82.175M
60.75%
EBIT
YoY % growth
-274.7M
-0.55%		-272.2M
0.91%		-220.725M
18.91%		-125.709M
43.05%
Operating Margin
-353.08%-205.28%-94.31%-44.63%
EPS
YoY % growth
-4.18
13.53%		-3.94
5.74%		-3.79
3.81%		-1.44
62.05%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.22
64.46%
Revenue
Q2Q % growth		89.762M
28.60%
EBITDA
Q2Q % growth		18.36M
143.99%
EBIT
Q2Q % growth		-16.779M
68.41%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.37
77.30%		-0.390.024.62%
Q2 2024
Q2Q % growth		 -0.36
55.00%		-0.540.1833.41%
Q1 2024
Q2Q % growth		 -0.58
21.62%		-0.770.1924.18%
Q4 2023
Q2Q % growth		 -0.62
34.74%		-0.740.1216.06%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 119.758M
110.93%		70.222M49.536M70.54%
Q2 2024
Q2Q % growth		 65.389M
12.48%		67.382M-1.993M-2.96%
Q1 2024
Q2Q % growth		 51.936M
5.28%		57.766M-5.83M-10.09%
Q4 2023
Q2Q % growth		 69.799M
39.82%		63.359M6.44M10.16%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS39.58% 39.58% 0% 32.75%
Revenue3.19% 3.19% 0% -0.53%